Head-to-head · WeighScore
GetRelief Rx vs telos rx
By GLP-1 ScorecardUpdated
Score comparison
telos rx has the higher recorded score — 85.4/100 to 58.9/100.
telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telos offers compounded oral and injectable formats; discounted plans can carry early-exit adjustments.
Before you choose
Before comparing the headline prices, the GetRelief Rx review and the telos rx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, GetRelief Rx vs Tyde Wellness and Go Vida Plena vs telos rx compare each of them with another graded program, and the list of alternatives to GetRelief Rx ranks the programs closest to GetRelief Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | GetRelief Rx | telos rx |
|---|---|---|
| WeighScore | 58.9/100 | 85.4/100 |
| Grade | C | B |
| Site position | #386 | #13 |
| Semaglutide | Advertised term totals $418 for two months or $1,134 for six; confirm billing | Advertised from $99/month injectable; plan-dependent; selected bill unverified. |
| Tirzepatide | Advertised term totals $718 for two months or $1,914 for six; confirm billing | Advertised from $139/month injectable; from $116/month microdosed injection; selected bills unverified. |
| Coverage | See provider service-area list; confirm eligibility | Advertises all 50 states; pharmacy and formulation availability varies. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Publishes separate totals for two- and six-month terms
- Public policy describes account and support cancellation
What to consider
- Selected first charge and post-term renewal need confirmation
- Refill processing can start up to seven days before the next billing cycle
Strengths
- Names its care organization and pharmacy partners
- Oral and injectable compounded options
What to consider
- Early cancellation can reprice supplied months
- Entity, denial-refund and lab terms conflict
- Current oral invoice and renewal price unverified
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.